HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction.

AbstractBACKGROUND:
Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms.
AIMS:
To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure.
METHODS:
Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]<45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months.
RESULTS:
At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2+/-10.8 to 39.2+/-10.1 mg/dl at 3 months, p=0.014; creatinine 1.1+/-0.23 to 0.98+/-0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151+/-91 to 122+/-14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80+/-10 to 87+/-13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19+/-5.96 to 2.88+/-4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115+/-87 to 168+/-155 pg/ml, p=0.004).
CONCLUSION:
Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased.
AuthorsEnrique Galve, Anna Mallol, Robert Catalan, Jordi Palet, Stella Méndez, Elsa Nieto, Anna Diaz, Jordi Soler-Soler
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 7 Issue 5 Pg. 892-8 (Aug 2005) ISSN: 1388-9842 [Print] England
PMID16087141 (Publication Type: Journal Article)
Chemical References
  • Diuretics
  • Sodium Potassium Chloride Symporter Inhibitors
  • Atrial Natriuretic Factor
  • Renin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Atrial Natriuretic Factor (blood)
  • Diuretics (pharmacology, therapeutic use)
  • Female
  • Heart Failure (blood, drug therapy, physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Renin (blood)
  • Sodium Potassium Chloride Symporter Inhibitors (pharmacology, therapeutic use)
  • Substance Withdrawal Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: